The recent merger between two of the largest players in the narrow preclinical drug discovery informatics space (Symyx and Accelrys) makes it timely to comment on merger and post merger opportunities and impacts:
That said, during the period of integration and uncertainty it is a wonderful opportunity for buyers and sellers to explore and consider new technologies and services. Our hypothesis over the past 6 years is that a technology built in the cloud from day one inherently has a number of advantages. These include a faster rate of innovation, lower cost of delivery and support, and lower total cost of ownership. Also, an inherently collaborative platform is a better way to securely share data between projects and organizations – and comes with a constantly growing community of collaborative researchers rapidly co-evolving with software and data.
In short, it is an exciting and challenging time for the merging partners. But for the marketplace, it opens up opportunities for the open-minded customers and vendors. We welcome the churn!
This blog is authored by members of the CDD Vault community. CDD Vault is a hosted drug discovery informatics platform that securely manages both private and external biological and chemical data. It provides core functionality including chemical registration, structure activity relationship, chemical inventory, and electronic lab notebook capabilities!
CDD Vault: Drug Discovery Informatics your whole project team will embrace!
Translated with Google Translate